Home » Exor continues to invest in the tech & health sector with 10.1% in Clarivate

Exor continues to invest in the tech & health sector with 10.1% in Clarivate

by admin
Exor continues to invest in the tech & health sector with 10.1% in Clarivate

TURIN – Exor, holding of the Agnelli Elkann family, rises to 10.1% of Clarivate, a company based in London and listed on the NYSE, which collects, processes and offers its customers the results of scientific and academic studies and research carried out all over the world, in various fields including health. Position that Exor has built over the course of a year.

The nomination of Suzanne Heywood

The agreement includes the appointment of Suzanne Heywood to the company’s board of directors. Exorwhich also controls Republic, become a long-term investor in Clarivate, with the possibility of increasing your stake up to 17.5%.

Stellantis, “record results” in 2023: profit reaches 18.6 billion by Diego Longhin 15 February 2024

A further step by Exor in the field of tech and health, after recent investments in Philips, Institut Mérieux, and Lifenet. “We are pleased to become shareholders of Clarivate, a global provider of data, analytics, technology and specialty services across multiple industries, including healthcare. We bring to the Board of Directors our experience of building great companies and look forward to help Clarivate express its full potential to achieve ambitious goals”, comments Suzanne Heywood.

All of the world‘s leading pharmaceutical and biotechnology companies use Clarivate’s services to improve patient care outcomesand accelerate research and innovation in the development and commercialization of new medicines.

Ferrari distributes 440 million in dividends by Diego Longhin 23 February 2024

Clarivate photography

50% of Clarivate’s revenue comes from solutions and content for academic and government institutions. The main products in this area are ProQuest and Web of Science. ProQuest provides services and information for libraries, offering access to theses, digital books, journals, historical, archival, government and cultural collections, as well as other aggregated databases. Web of Science is the main database with references and citations on scientific content consulted by academics and researchers all over the world. The world‘s leading universities use solutions offered by Clarivate. The rest of the turnover comes from data, software and services for patents, trademarks and domains, and from databases and services in the medical fieldstarting from pharmacological formulas.

Jonathan Gear, CEO of Clarivate said: “We welcome Exor’s commitment to support our strategy as a long-term investor. I am encouraged by their vote of confidence, which reflects their appreciation of our ability to deliver solutions that our customers rely on to achieve the most important discoveries in the world“. Andy Snyder, president of Clarivateadded: “We are thrilled to have Suzanne join our board of directors. Suzanne will bring with her deep experience from multiple roles on the boards of directors of large global companies, and her leadership will be invaluable as we continue to transform Clarivate into a world-leading reality that provides information and knowledge”.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy